These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer. Puccetti L; Supuran CT; Fasolo PP; Conti E; Sebastiani G; Lacquaniti S; Mandras R; Milazzo MG; Dogliani N; De Giuli P; Fasolis G Eur Urol; 2005 Aug; 48(2):215-21; Discussion 221-3. PubMed ID: 15992991 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Bonkhoff H Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy. May M; Siegsmund M; Hammermann F; Loy V; Gunia S Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019 [TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation. Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features. Alberti C G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in the progression of prostate cancer. Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524 [TBL] [Abstract][Full Text] [Related]
12. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293 [TBL] [Abstract][Full Text] [Related]
13. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cox ME; Deeble PD; Lakhani S; Parsons SJ Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001 [TBL] [Abstract][Full Text] [Related]
14. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Zhang Y; Huang D; Yu G Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications. Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors. Wafa LA; Palmer J; Fazli L; Hurtado-Coll A; Bell RH; Nelson CC; Gleave ME; Cox ME; Rennie PS Hum Pathol; 2007 Jan; 38(1):161-70. PubMed ID: 16997353 [TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells. Untergasser G; Plas E; Pfister G; Heinrich E; Berger P Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938 [TBL] [Abstract][Full Text] [Related]
20. Receptors for BPH growth factors are located in some neuroendocrine cells. Iwamura M; Koshiba K; Cockett AT Prostate Suppl; 1998; 8():14-7. PubMed ID: 9690658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]